PHILADELPHIA, Sept. 4, 2024 /PRNewswire/ -- Signant Health, the
leader in evidence generation for modern clinical trials, announced
today it has joined IQVIA, a leading global provider of advanced
analytics, technology solutions, and clinical research services to
the life sciences industry, in its One Home for Sites™
initiative.
IQVIA One Home for Sites is an industry-wide collaboration
designed to simplify site conduct when clinical research staff
leverage multiple eClinical technologies from multiple solution
providers on a trial. Through single sign-on to a common platform,
sites enjoy simplified access to trial technologies from IQVIA and
other technology partners that have taken the steps to participate
in One Home.
One such technology solution that will appear on the One Home
for Sites platform is Signant SmartSignals® Unified Platform,
itself a fully integrated solution consisting of eCOA, EDC, RTSM,
eConsent, and telemedicine.
"We are very pleased to have our Unified Platform now available
within One Home for Sites," said Sanjiv
Waghmare, Signant's chief product officer. "IQVIA's
industry-wide, collaborative approach aligns well with our overall
product strategy to homogenize access to all our products through a
single environment we call Signant SmartSignals® ID Portal. We
applaud IQVIA's efforts to extend this philosophy by consolidating
multiple solution providers into one ecosystem for easy access by
sites."
"Signant Health quickly recognized the power of One Home for
Sites to capture synergies across the industry and deliver a better
experience to sites," said Melissa
Easy, VP of Commercialization for IQVIA Technologies Digital
Products and Services. "We welcome Signant to One Home and look
forward to their continued contribution to building the
next-generation clinical trial ecosystem that benefits all
stakeholders – especially the patients we serve."
About Signant Health
Signant Health is the evidence generation company. We are
focused on leveraging software, deep therapeutic and scientific
knowledge, and operational expertise to consistently capture,
aggregate, and reveal quality evidence for clinical studies across
traditional, virtual, and hybrid trial models. For more than 25
years, over 600 sponsors and CROs of all sizes – including all Top
20 pharma – have trusted Signant solutions for remote and
site-based eCOA, EDC, eConsent, RTSM, supply chain management, and
data quality analytics. Learn more
at www.signanthealth.com.
About IQVIA
IQVIA (NYSE: IQV) is a leading global provider of clinical
research services, commercial insights and healthcare intelligence
to the life sciences and healthcare industries. IQVIA's portfolio
of solutions are powered by IQVIA Connected Intelligence™ to
deliver actionable insights and services built on high-quality
health data, Healthcare-grade AI™, advanced analytics, the latest
technologies and extensive domain expertise. With approximately
88,000 employees in over 100 countries, including experts in
healthcare, life sciences, data science, technology and operational
excellence, IQVIA is dedicated to accelerating the development and
commercialization of innovative medical treatments to help improve
patient outcomes and population health worldwide.
IQVIA is a global leader in protecting individual patient
privacy. The company uses a wide variety of privacy-enhancing
technologies and safeguards to protect individual privacy while
generating and analyzing information on a scale that helps
healthcare stakeholders identify disease patterns and correlate
with the precise treatment path and therapy needed for better
outcomes. IQVIA's insights and execution capabilities help biotech,
medical device and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders tap
into a deeper understanding of diseases, human behaviors and
scientific advances, in an effort to advance their path toward
cures. To learn more, visit www.iqvia.com.
Contact:
Heather
Bilinski
media@signanthealth.com
+1 610.400.4141
View original
content:https://www.prnewswire.co.uk/news-releases/signant-health-expands-availability-of-its-eclinical-solutions-by-joining-iqvia-one-home-for-sites-initiative-302233403.html
